Direct Oral Anticoagulants: From Randomized Clinical Trials to Real-World Clinical Practice

Direct oral anticoagulants (DOACs) are a more manageable alternative than vitamin K antagonists (VKAs) to prevent stroke in patients with nonvalvular atrial fibrillation and to prevent and treat venous thromboembolism. Despite their widespread use in clinical practice, there are still some unresolve...

Descripción completa

Detalles Bibliográficos
Autores principales: Roberti, Roberta, Iannone, Luigi Francesco, Palleria, Caterina, Curcio, Antonio, Rossi, Marco, Sciacqua, Angela, Armentaro, Giuseppe, Vero, Ada, Manti, Antonia, Cassano, Velia, Russo, Emilio, De Sarro, Giovambattista, Citraro, Rita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188985/
https://www.ncbi.nlm.nih.gov/pubmed/34122113
http://dx.doi.org/10.3389/fphar.2021.684638

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188985/
https://www.ncbi.nlm.nih.gov/pubmed/34122113
http://dx.doi.org/10.3389/fphar.2021.684638

Ejemplares similares